Blood Cancers, Therapeutic Progress, and the Impact of COVID on Research
Gwen Nichols, M.D., Chief Medical Officer at the Leukemia & Lymphoma Society discusses blood cancers, the progress in blood cancer therapies, and the im...
5328 articles
Gwen Nichols, M.D., Chief Medical Officer at the Leukemia & Lymphoma Society discusses blood cancers, the progress in blood cancer therapies, and the im...
Clinician safety is the top priority during the COVID-19 crisis. Learn more on Health Professional Radio.
Recent research suggests that the loss of muscle mass is associated with compromised immunity and infections. Dr. Learn more on Health Professional Radio.
David Spetzler, President and Chief Scientific Officer at Caris® Life Sciences discusses partnering with Merus, a clinical-stage oncology company, to d...
Avi Fischer, M.D., Divisional Vice President, MedicalAffairs, and Chief Medical Officer for Cardiac RhythmManagement (CRM) at Abbott discusses the recen...
Ruby Gadelrab, CEO and Co-founder of MDisrupt, the first-of-its-kind medical diligence company, discusses how they are helping health-tech startups demo...
Wesley Gilson, Ph.D., Artificial Intelligence Lead for Siemens Healthineers North America discusses the idea that an AI revolution in healthcare is not ...
Kathryn Lang, vice president of Health Outcomes and Evidence at Guardant Health discusses research highlighting the significance of its LUNAR-2 liquid b...
Steve Tilles, Senior Director of Medical Affairs at Aimmune Therapeutics, the first company to gain FDA approval of a peanut allergy treatment, PALFORZI...
Susan Mitmesser, VP of Science and Technology at Pharmavite, makers of Nature Made vitamins and supplements, discusses a review paper by Pharmavite that...